OTC · Financial Statements

Drug Free Solution, Inc. (DSOL) Financial Statements

$0.00 OTC: DSOL Market Cap $113361

Drug Free Solution, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202220232024
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$0$0$0
Net Profit$-1.0M$-1.0M$0$0$0
EPS$-0.01$0.00$0.00$0.00$0.00
Op Margin-82066.8%-174817.4%———

Balance Sheet (USD)

Metric20182019202220232024
Total Assets$0$0———
Total Liabilities$0$0———
Cash$0$0———
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20182019202220232024
Operating Cash Flow$0$0———
Investing Cash Flow$0$0———
Financing Cash Flow$0$0———
Net Cash Flow$0$0———
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.17
EV / EBITDA-15.07
FCF Yield-370.26%
Quick Ratio0.04
Interest Coverage0.00
Return 1Y100.00%
Return 3Y100.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
DSOL Overview DSOL Dividend Run Stock Screener